32 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
capabilities and increase commercial supply of CARVYKTI®
Published inaugural Environmental, Social & Governance (ESG) report which aligns with the Sustainable
F-3ASR
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
administrative burden and restrict our non-PRC and cross-border investment activity.
Monetary, economic, political, environmental, social, and trade
F-3ASR
yreyb3
26 May 23
Automatic shelf registration (foreign)
9:01am
424B5
95vp wyc9aqe83vh
8 May 23
Prospectus supplement for primary offering
8:45am
D
9ur935
28 Apr 23
$200.00 mm in equity, sold $200.00 mm, 1 investor
4:10pm
6-K
EX-99.1
wnn3p7d10g6c2
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
CORRESP
02fwtn96buzcrmi
11 Oct 22
Correspondence with SEC
12:00am
CORRESP
5e7kum3l
30 Sep 22
Correspondence with SEC
12:00am
6-K
EX-1.1
sae99px uhe7750
27 Jul 22
Announces Pricing of Public Offering
4:35pm
424B5
ska5w9q w4g9gy
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
u0enfwk etw
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.4
h33hs12mui4hc0k1r
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-1.1
bsb9e6
17 Dec 21
Announces Pricing of Public Offering
4:19pm
424B5
2jc88jhbi 007tfi
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
cigdc
14 Dec 21
Prospectus supplement for primary offering
4:40pm